Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $174.29 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $53.85 | 3 | $0 (2024) |
| Axsome Therapeutics, Inc. | $41.47 | 2 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32.08 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $16.57 | 1 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $16.46 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.86 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140.54 | 8 | Axsome Therapeutics, Inc. ($41.47) |
| 2023 | $33.75 | 2 | Lilly USA, LLC ($19.89) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: PSYCHIATRY | ||||||
| 06/03/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/20/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 01/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Diabetes | ||||||
| 03/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 162 | 234 | $42,040 | $17,420 |
| 2022 | 4 | 71 | 105 | $23,370 | $10,196 |
| 2021 | 7 | 159 | 225 | $53,939 | $19,511 |
| 2020 | 3 | 91 | 139 | $46,736 | $16,032 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 39 | 54 | $12,960 | $5,586 | 43.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 28 | 62 | $10,540 | $4,794 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 30 | $4,800 | $1,827 | 38.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 31 | 36 | $4,320 | $1,760 | 40.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,080 | $1,347 | 33.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 20 | 22 | $2,640 | $1,184 | 44.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 18 | $2,700 | $921.42 | 34.1% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 34 | 62 | $14,880 | $6,948 | 46.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 15 | $3,900 | $1,301 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 17 | $2,720 | $1,027 | 37.7% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 11 | 11 | $1,870 | $919.58 | 49.2% |
| 99350 | Established patient home visit, typically 60 minutes | Office | 2021 | 33 | 64 | $15,360 | $7,179 | 46.7% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2021 | 31 | 59 | $7,080 | $2,968 | 41.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 29 | 32 | $8,320 | $2,819 | 33.9% |
| 99345 | New patient home visit, typically 75 minutes | Office | 2021 | 16 | 16 | $10,048 | $2,189 | 21.8% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2021 | 22 | 25 | $4,250 | $2,066 | 48.6% |
| 99344 | New patient home visit, typically 60 minutes | Office | 2021 | 13 | 13 | $6,721 | $1,543 | 23.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 16 | $2,160 | $746.88 | 34.6% |
| 99350 | Established patient home visit, typically 60 minutes | Office | 2020 | 40 | 88 | $21,120 | $9,763 | 46.2% |
| 99345 | New patient home visit, typically 75 minutes | Office | 2020 | 37 | 37 | $23,236 | $5,086 | 21.9% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2020 | 14 | 14 | $2,380 | $1,183 | 49.7% |
About Kelsey Mccaslin, NP-C
Kelsey Mccaslin, NP-C is a Nurse Practitioner healthcare provider based in Vincennes, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1659853273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelsey Mccaslin, NP-C has received a total of $174.29 in payments from pharmaceutical and medical device companies, with $140.54 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($174.29).
As a Medicare-enrolled provider, Mccaslin has provided services to 483 Medicare beneficiaries, totaling 703 services with total Medicare billing of $63,160. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Vincennes, IN
- Active Since 08/30/2018
- Last Updated 08/06/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1659853273
Products in Payments
- JARDIANCE (Drug) $53.85
- Auvelity (Drug) $41.47
- CAPLYTA (Drug) $32.08
- BREZTRI (Drug) $16.57
- JORNAY PM (Drug) $16.46
- GATTEX (Drug) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Vincennes
Rebecca Akers, A.n.p., F.n.p, A.N.P., F.N.P
Nurse Practitioner — Payments: $7,117
Stephanie Fuller, Fnp-C, FNP-C
Nurse Practitioner — Payments: $4,454
Amber Matthews, Aprn, APRN
Nurse Practitioner — Payments: $1,360
Amy Ethridge, Np, NP
Nurse Practitioner — Payments: $1,326
Andrea Miller, Np, NP
Nurse Practitioner — Payments: $947.26
Brett Eaton, Aprn, APRN
Nurse Practitioner — Payments: $596.35